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ABSTRACT: Anisotropic nanostructures, such as nanotubes,
incorporating bioactive molecules present interesting features for
application as drug delivery carriers. Here, we present the
synthesis of layer-by-layer (LbL) nanotubes including protein
(ovalbumin) layers and go from simple to more complex
synergetic combinations of synthetic and natural polyelectrolytes,
leading to structures with tunable properties. The rigidity in
organic and aqueous media, the stability in buffer solution and the
uptake of different LbL tubes by dendritic cells (DCs) are
analyzed to contrast size and chemistry. The most rigid studied
systems appear as the best candidates to be internalized by cells,
regardless of the chemistry of their outermost layers. The
successful transport of long protein-loaded robust rigid nanotubes to the cytoplasm of DCs paves the way for their use as new
cargo for the delivery of large amounts of antigen to such cells.
■ INTRODUCTION
Micro- and nanosized particles are an interesting alternative to
conventional drug carriers due to their potential to minimize
dosage, spread it over time, and localized delivery.1 Nanometer
sized objects are also advantageous to cross biological barriers,
whereas the large surface-to-volume ratio inherent to
submicron sized objects opens new and exciting possibilities
to develop better personalized therapies.
Layer-by-layer (LbL) deposition is a well-established
technique with strong potential for the development of drug
carriers.2−4 Its versatility, simplicity, and use of aqueous
conditions makes it an interesting alternative to prepare
micro- and nanomaterials of diverse geometry, combining
many possible components of complementary charge and
chemistry. The method is also attractive because it allows to
incorporate a large range of functionalities, some of them
possibly helping drugs to reach specific sites and/or to exhibit
sustained release.
So far, most research efforts for LbL-based drug delivery have
addressed the synthesis of spherical particles, such as protein-
containing nanocapsules or spherical nanoparticles.5−9 How-
ever, recent reports suggest that the use of an anisotropic
geometry of higher aspect ratio would increase the chances of
internalization.10 Moreover, the shape of the carriers may as
well affect the crossing speed of cellular barriers and their
performance.11−13 Therefore, it appears timely and relevant to
study the LbL synthesis of high aspect ratio nanotubes as
potential drug carriers.
Nanotubes can be prepared via LbL assembly using a
sacrificial hard-template, such as a porous membrane, into the
pores of which polycation and polyanion layers are deposited in
an alternate fashion.14,15 The membranes commonly employed
as LbL templates are made of polycarbonate (PC) or alumina
(AAO). Given that template removal is necessary to obtain free
nanotubes, the nature of the membrane restricts the nanotube
application, as AAO dissolves at either pH ≤ 4.5 or pH ≥ 8.5,
conditions which are not frequently compatible with
components of biological origin, whereas PC dissolution
requires an organic solvent, such as dichloromethane,
conditions which are hardly better. LbL templating must
therefore lead to assemblies able to resist the contact with acid,
base or organic solvent to successfully recover the nanotubes.
For nanotubes used for drug delivery, which include
biocompatible elements such as polysaccharides, proteins or
polypeptides, this can be challenging. We and several authors
have reported the synthesis of protein16−19 and hybrid20−23
LbL nanotube architectures for biomedical applications.
Though, among those, only one work explored the interaction
of free LbL nanotubes with cells.24
Among possible applications of protein-based LbL nano-
tubes, we focus our attention on vaccine vectors to boost the
immune response against codelivered antigens. A recently
developed strategy is targeting the in situ delivery of an antigen
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to dendritic cells (DCs),25,26 which capture and present it at
their surface to T-cells. For example, the ovalbumin protein and
its derivate peptide SIINFEKL have been used as model
antigens and encapsulated in spherical LbL-particles,26,27
thereby proving that T-cell cross presentation in dendritic
cells is enhanced in vitro and in vivo with submicron LbL
carriers.
In the present work, we report on the hard-templating
combined with LbL deposition of long protein-based
polyelectrolyte nanotubes of different chemistry, on their
stability in aqueous media and on their in vitro uptake by
DCs. We use the term long nanotubes to refer to structures of
400 or 500 nm diameter having an aspect ratio of about 25 or
40, respectively. In a first stage, we fabricate LbL nanotubes
based on synthetic polyelectrolytes or on ovalbumin and
polypeptides as building blocks. We evaluate their stability in
organic solvents and in aqueous media, and then compare their
uptake by DCs. Based on these results, we propose a core−shell
nanotube architecture consisting of a biocompatible protein-
rich compartment and a rigid synthetic compartment,
reminiscent of an earlier proposition by Rubner et al.,24 and
study cell internalization for long times of interaction with DC
cells and different nanotube architectures (in contrast to
Rubner et al.’s previous study24 which concentrated on
adsorption for much shorter times). Our study demonstrates
that the uptake of long, intact nanotube by dendritic cells is
possible, provided a proper architecture be selected for the
nanotubes.
■ MATERIALS AND METHODS
Materials. Poly(allylamine hydrochloride) (PAH, Mw: 58 kDa),
poly(sodium 4-styrenesulfonate) (PSS, Mw: 70 kDa), poly-L-arginine
(PLA, Mw > 70 kDa), ovalbumin (OVA, Mw: 45 kDa), and
poly(allylamine hydrochloride) fluorescein isothiocyanate (PAH*,
Mw: 15 kDa maximum excitation at 495 nm and maximum emission
at 521 nm) with a monomer to dye ratio (PAH/FITC) of (50:1),
dichloromethane (CH2Cl2), sodium chloride, N-hydroxysulfosuccini-
mide sodium salt (sulfo-NHS), N-(3-(dimethylamino)propyl)-N′-
ethylcarbodiimide hydrochloride (EDC), dextran from Leuconostoc
spp., Mw: 40 kDa, and ethylenediaminetetraacetic acid (EDTA) were
purchased from Sigma-Aldrich. Poly-L-ornithine hydrobromide (PLO)
Mw 78 kDa, was acquired from Alamanda Polymers. Sodium
hyaluronate (HA, Mw: 176−350 kDa) was purchased from Life
Core. Ovalbumin Alexa Fluor 488 (OVA*) was purchased from Life
Technologies. The Alexa Fluor 488 fluorophore has a maximum
excitation peak at 496 nm and a maximum emission peak at 519 nm,
according to the supplier. Dulbecco’s phosphate-buffered saline (PBS)
without calcium nor magnesium was purchased from Thermo-
Scientific. Tris(hydroxymethyl)aminomethane (Tris) was purchased
from Acros. (S)-2-Pyridylthio cysteamine hydrochloride (PDA) was
bought from CarboSynth Limited. Fluorescein functionalized RGD
peptide with a cysteine end (FITC- KRGDSPC) was purchased from
Genecust. All aqueous solutions were prepared using deionized water
with a resistivity of 18.2 MΩ.cm at 25 °C.
Sheets of track-etched PC membranes were provided by It4ip
(Louvain-la-Neuve, Belgium, http://www.it4ip.be) with the following
dimensions: 400 nm pore diameter, 10 μm thickness and 1 × 108
pores·cm−2, and a different set with 500 nm pore diameter, 21 μm
thickness, and 1 × 108 pores·cm−2. Pore diameters of the PC
membrane can vary by about 5−10%. Hydrophilic poly(ethylene
terephtalate) (PET) membranes with a pore size of 200 nm were also
provided by It4ip.
All polyelectrolyte solutions were prepared at 1 mg·mL−1
concentration except for fluorescent OVA* and PAH*, which were
prepared at 0.1 and 0.5 mg·.mL−1, respectively. Polyelectrolytes were
typically dissolved in 150 mM NaCl without any pH adjustment,
unless stated otherwise.
LbL Assembly by Dipping. The PC membrane was alternately
dipped in polycation and polyanion solutions for 30 min, starting with
the polycation adsorption since the PC membrane is negatively
charged. Each adsorption step was followed by an intermediate two-
step rinsing (2 min each) in two baths of aqueous solution of same
ionic strength and pH as used for the polyelectrolytes. Next, the
membrane was dipped in the polyanion solution for 30 min and rinsed
(two steps, 2 min each). The surface of the membrane was cleaned
with a cotton swab to prevent pore blockage. The process was
repeated until the desired number of layer pairs was obtained. LbL-
modified PC membranes were rinsed abundantly with deionized water
and subsequently immersed in PBS buffer for at least 24 h at room
temperature.
LbL assembly by filtration. A circular piece of PC membrane was
held in a stainless steel syringe filter holder and the polycation/
polyanion solutions were alternately passed through the membrane to
adsorb polyelectrolyte layers in the pores of the membrane (3 mL of
solution for each step, 1 mL·min−1). Two rinsing steps followed
similarly, using solutions of same ionic strength and pH as the
polyelectrolyte ones (twice, 3 mL of solution for each step, 1 mL·
min−1). Immediately after rinsing, the surface of the membrane was
cleaned with a cotton swab to prevent pore blockage. Then, a layer of
an oppositely charged polyelectrolyte was filtered and the process was
repeated until three bilayers of polycation/polyanion. LbL-modified
PC membranes were rinsed abundantly with deionized water and
immersed in PBS buffer for at least 24 h at room temperature.
FITC-Peptide Conjugation on LbL-Nanotubes. The protocol
followed by Caruso et al.28 was adapted to conjugate a cysteine-FITC-
functionalized peptide on HA polymer chains. Briefly, a PC membrane
modified by LbL assembly and containing HA layers was immersed
overnight in a solution containing 25 mM EDC, 48 mM sulfo-NHS,
and 50 mM PDA to install disulfide bonds on the tubes. Then the
membrane was extensively rinsed in deionized water and subsequently
immersed in a 0.1 mg/mL FITC-KRGDSPC peptide solution in Tris-
EDTA buffer (10 mM, pH 7.5) for 24 h to promote FITC conjugation
via thiol−disulfide exchange. Finally, the membrane was extensively
rinsed in deionized water and stored at 4 °C.
Gas Flow Porometry. Average pore diameter of PC membranes
was calculated after gas-flow porometry measurements before and after
LbL assembly. For the measurement, a dry PC membrane was firmly
held inside a membrane holder with an effective section area of 0.396
cm2. Nitrogen gas at room temperature was flown upstream with a
pressure ranging from 4 to 10 psi. The gas flow rate (mL/min)
downstream from the sample was measured by a flowmeter (Agilent).
The inner diameter of the pores was calculated by using Knudsen
diffusion and the viscous or Hagen−Poiseuille flow relationship, as
described elsewhere.29
Releasing LbL-Nanotubes from the Template for Imaging.
The LbL-modified PC membrane was immersed in dichloromethane
and gently stirred to dissolve PC. The nanotubes were then recovered
by filtration of the colloidal suspension over a PET membrane. To
maximize the removal of remnant PC, fresh CH2Cl2 was flushed
through the PET filters several times.
Collection and Redispersion of LbL-Nanotube in Water or
PBS Solutions. We used a previously reported protocol to transfer
the LbL nanotubes into an aqueous solution and avoid agglomer-
ation.30 Briefly, 20−25 mg of dextran powder was dispersed in a few
mL of dichloromethane and filtered over a PET membrane to form a
porous dextran cake. Separately, 1 cm2 of LbL-modified PC membrane
was dissolved in an equal volume of dichloromethane and mixed with
20−25 mg of dextran powder before being filtered on top of the
dextran cake. An excess of CH2Cl2 was flushed throughout the porous
pellet of nanotubes and dextran to ensure full PC removal.
Immediately after the solvent was evaporated, the pellet made of
dextran and nanotubes (ca. 1 × 108 nanotubes) was mixed with 1−2
mL of water or sterile PBS buffer and the suspension was stirred for 15
min, allowing the tubes to be dispersed in the aqueous solution after
dextran dissolution. Template removal and nanotube dispersion of the
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tubes used for cell assays was done in sterile conditions (biologically
safe laminar flow hood) to avoid bacterial contamination.
STEM Microscopy. A few droplets of the nanotube dispersion (in
PBS or dichloromethane) were dropped over a TEM grid (200 mesh,
Electron Microscopy Sciences), followed by a few more droplets of
pure water or dichloromethane. Then, the grid was left to dry at room
temperature.
The samples were observed at 30 keV with a Field Emission
Scanning Electron Microscope (JSM-7600F, Jeol Ltd.) equipped with
a transmission detector.
Epi-Fluorescence Microscopy. The suspension of fluorescent-
tagged nanotubes was either observed dry after collection on a PET
filter, or observed in the wet state in a chambered coverglass.
Fluorescence images were obtained by an Olympus IX2 inverted
microscope equipped with a FITC filter set.
Calculation of LbL Nanotube Rigidity. Epi-fluorescence and
STEM images were analyzed using the Image-J software to calculate
the rigidity index of the tubes which is defined as ⟨REE
2⟩/L2, as we
previously reported.30 The root-mean-square end-to-end distance of
the nanotubes ⟨REE
2⟩1/2 and their average contour length ⟨L⟩ were
measured for at least 25 different tubes for each system to obtain
meaningful average and standard deviation values.
Cell Culture. DC2.4 cells were cultured in DMEM (Dulbecco’s
Modified Eagle Medium) supplemented with 10% FBS (fetal bovine
serum) and antibiotics (100 units per mL penicillin and 100 μg·mL−1
streptomycin). Cells were grown at 37 °C in humidified air containing
5% CO2. DC2.4 cells were plated out on Willco-Dish glass bottom
dishes (30000 cells, suspended in 200 μL of culture medium) and
incubated overnight. Next, the cells were pulsed with 10 μL of
nanotubes stock solutions and incubated overnight at 37 °C. The
following day, cells were fixed and stained with Hoechst and CTB-
AF555. Briefly, culture medium was aspirated and cells were washed
with PBS. Next, 200 μL of 4% paraformaldehyde was added and
allowed to fixate for 30 min. A staining solution was prepared by
adding blue Hoechst (10 μL, of a 2 mg/mL stock in PBS) and red
CTB-AF555 (5 μL of a 1 mg/mL stock in PBS) to a PBS buffer
containing 1% of BSA (2 mL). After aspiration and washing, 200 μL of
this staining solution was added to the fixed cells and incubated for 30
min at 37 °C. Finally, the samples were washed with 1% BSA PBS
buffer and stored on ice.
Confocal Microscopy. Confocal microscopy was carried out with
a Leica DMI6000 B inverted microscope equipped with an oil
immersion objective (Leica, magnification: 63×, numerical aperture:
1.40) and attached to an Andor DSD2 confocal scanner. Images were
processed with ImageJ and Imaris software.
■ RESULTS AND DISCUSSION
We assembled polyelectrolyte nanotubes within the pores of
polycarbonate membranes via LbL, promoting polyelectrolyte
adsorption by filtration or dipping methods (Scheme 1, step 1).
Both methods lead to LbL nanotubes, but we observed that
the pores of a membrane are saturated “faster” (with less LbL
cycles) by filtration. Our observations indicate that thicker
layers can be obtained when the polyelectrolyte solution is
forced through the pores by applying pressure (data not shown
here). Thus, in a first stage we used filtration to quickly
synthesize and analyze three different polyelectrolyte pairs. Yet,
to obtain core−shell nanotubes, we used dipping since we
target to add at least two different polyelectrolyte pairs with
different chemistry. Moreover, the dipping method allows us to
produce larger amounts of sample in parallel (contrary to
filtration, where the area of the gasket is a limiting factor),
which is of relevance for the cell assays.
Different polyelectrolytes pairs were used to compare the
properties of the resulting nanotubes, ranging from fully
synthetic to protein-based materials, made either from a single
pair of polyelectrolytes or comprising compartments of
different compositions (hereafter called core−shell structures),
as indicated in Table 1.
Simple Polycation/Polyanion LbL Nanotubes. In the
first stage, we selected three simple polycation/polyanion
Scheme 1. Schematic of the Elaboration of LbL Nanotubes in Polycarbonate (PC) Templates and of Their Release in CH2Cl2
and Their Dispersion in PBS Buffer
Table 1. Summary of the Composition and Build-up Conditions of the LbL Nanotubesa
simple polycation/polyanion LbL tubes building medium method of assembly
i (PAH*/PSS)3 150 mM NaCl filtration
ii (PAH/OVA*)3 10 mM HEPES, pH 8
iii (PLA/OVA*)3 150 mM NaCl
shell core
iv (PLO/HA)6 (PAH/PSS)4/(PAH*/PSS)2 100 mM NaCl, with 5 mM CaCl2 dipping
v (PLO/OVA*)6 (PAH/PSS)6 100 mM NaCl, with 5 mM CaCl2
vi (PAH/PSS)6 (PLO/HA)4/(PLA/OVA*) 100 mM NaCl, with 5 mM CaCl2
vii (PLO/HA)4/(PLA/OVA*) (PAH/PSS)6 100 mM NaCl, with 5 mM CaCl2
aA star indicates a fluorescently-tagged macromolecule.
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systems of contrasting chemistry (Table 1, i−iii), that is, (i)
PAH/PSS, as quintessential synthetic robust polyelectrolyte
pair; (ii) PAH/OVA to insert a protein as a polyanion while
keeping a synthetic polycation, and finally, (iii) PLA/OVA with
exclusively polypeptide and protein layers. For these experi-
ments, we used a PC membrane of 500 nm nominal pore size
and 21 μm thickness. LbL-modified membranes were dried and
then brought in contact with dichloromethane to release the
tubes from the template. To evaluate nanotubes stability, we
compared them by epi-fluorescence (Figure 1) after their
release in organic solvent (CH2Cl2, sample collected right
away) or 24 h after their transfer into an aqueous solution (PBS
buffer), Scheme 1 (step 2). The length of the nanotubes after
template removal corresponds to the characteristic thickness of
the PC template (i.e., 21 μm), as can be easily measured in the
top row of Figure 1, showing tubes collected from the
methylene chloride suspension. However, there is a remarkable
difference with the second row of images, which shows tubes
after a 24 h dispersion in an aqueous solution, implying that the
LbL tubes are at least partially disrupted after being dispersed in
water. In addition, whereas PAH/PSS based tubes partially
preserve their geometrical features, OVA-containing nanotubes
are completely broken into pieces and strongly swollen after
exposure to water.
In a former publication,30 we introduced a rigidity index to
compare the morphology of the nanotubes in a more
quantitative manner. The rigidity index, ⟨REE
2⟩/L2, is defined
as the ratio between the root-mean-square of the end-to-end
distance (REE), and the square of the average contour length
(L). ⟨REE
2⟩/L2 is a dimensionless parameter ranging from 0 to
1: For a very rigid tube of persistence length Lp ≫ L, ⟨REE2⟩ =
L2 and the index of rigidity equals 1; for a less rigid tube with Lp
≪ L, the index of rigidity is 2Lp/L < 1, approaching 0 for an
infinitely flexible tube of zero persistence length. Using epi-
fluorescence images, we calculated the index of rigidity (Figure
2, bars i−iii). Nanotubes made of simple polyelectrolyte pairs
are generally very rigid and of well-preserved shape in the
organic solvent as shown by a rigidity index close to 1.
However, the nanotubes lose rigidity after water contact, with
the loss being smaller for PAH/PSS and higher for PLA/OVA.
This is due to the swelling of the tubes by water, resulting in a
decreased Young’s modulus, hence decreased persistence
lengths and rigidity indices. This result shows that, when
dispersed in an aqueous solution, the tubes soften due to
swelling, then deform and break more easily for biomacromo-
lecule-based assemblies, a trend in good agreement with a
previous report.30
The wall thickness of the LbL tubes of Figure 1 was
calculated after gas flow porometry measurements and
compared against our observations from Scanning Trans-
mission Electron Microscope (STEM) images. Based on gas
flow porometry we calculated the pore size of the membrane
before and after LbL deposition, leading to an estimation of the
wall thickness of the tubes, dwall (Table 2). Whereas the
nominal pore size of the template is 500 nm, we measured
about 440 ± 40 nm before any polyelectrolyte adsorption. The
(PAH/PSS)3 tubes have thinner walls compared to the protein-
based tubes, which is due to the synthetic layers adsorbing in
compact “flat” layers. Interestingly, the tubes measured by
STEM after template removal in CH2Cl2 have an external
diameter larger than the starting pore size of the template,
indicating a “flattening effect” that occurs when the tubes are
released from the membrane. The ratio between the diameter
of the flattened tubes to the starting diameter of the pores,
Dtube/Dpore, is an indicator of this flattening and of the softness
of the tubes; this ratio is larger for protein-based tubes, which is
in good agreement with their lower index of rigidity (Figure 2,
i−iii).
For the in vitro uptake of these nanotubes by DCs, they were
dispersed in PBS, pulsed on DCs and incubated overnight.
Afterward, the culture medium was removed and the cells were
fixed and stained for confocal imaging. To gather more
information about the uptake and the impact of the nanotube
Figure 1. Epi-fluorescence images of LbL nanotubes of different
composition in methylene chloride (a−c) and after (d−f) immersion
in PBS buffer for 24 h; left column (PAH*/PSS)3 (a, d); central
column (PAH/OVA*)3 (b, e); right column (PLA/OVA*)3 (c, f). All
tubes are initially 500 nm in diameter and 21 μm in length. Scale bar is
20 μm.
Figure 2. Rigidity index (⟨REE
2⟩/L2) for all the free polyelectrolyte
nanotubes of Table 1. The error bars represent the standard error on
the average value of at least 25 measurements.








Dtube, nm Dwall, nm Dtube/Dpore
(PAH/PSS)3 570 ± 35 35 1.29 ± 0.22
(PAH/OVA)3 781 ± 84 60 1.77 ± 0.40
(PLA/OVA)3 736 ± 61 60 1.67 ± 0.32
aThe membrane starting pore diameter (Dpore) is 440 ± 40 for the
three samples mentioned above.
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size we also included sets of shorter tubes, of 10 versus 21 μm
tube length. Figure 3 shows the confocal images acquired for
the uptake, where we notice that the three types of LbL
nanotubes penetrate the cell membrane. Moreover, we found
that the cells are viable after overnight exposure to our tubes.
Figure 3 reveals that fully synthetic PAH/PSS tubes (Figure
3a,b) preserve their shape and dimensions in the cell (and
culture medium). While the Figure 3b shows several well-
extended tubes, some long (PAH/PSS)3 tubes clearly bend to
fit inside the cells (DCs have a minor axis of ca. 15 μm). The
second row (Figure 3c,d) corresponds to (PAH/OVA)3: the
tubes are clearly broken except for a single tube, both the
fractured bits and the intact tube being inside the cells. The
bottom row (Figure 3e,f) shows that (PLA/OVA)3 tubes are
mostly present as very small fragments inside DCs. The
fragmentation of the protein-based nanotubes in the DCs
points to their high softness and prohibits concluding on their
uptake as tubes by the cells. Clearly, the use of synthetic
polyelectrolytes of high linear charge density such as PAH/PSS,
which are known to interact strongly, is required to preserve
tube shape and study internalization. Preserving tube shape
might be important for nanotube internalization, since recent
studies have demonstrated that hard particles are more easily
phagocytosed compared to soft particles.31
Therefore, in order to prepare stable drug carriers
incorporating ovalbumin for immunotherapy, we designed
multicompartment nanotubes. Thus, we assembled nanotubes
integrating a compartment containing protein or polysaccharide
layers, and a compartment made of synthetic layers (PAH/
PSS) in order to provide a rigid framework to the
nanostructures (Table 1, iv−vii). These nanotubes will be
thereafter called core−shell nanotubes.
Core−Shell LbL Nanotubes. Based on our previous
confocal observation that shorter tubes do not have to bend
to be internalized (Figure 3), we decided to only work with the
PC template of 10 μm thickness (and 400 nm nominal pore
diameter). Then, in order to better control the assembly of
layers of different polyelectrolyte pairs in the pores of the
membranes, we moved from filtration assembly to the dipping
method, in which the membrane is dipped into the
polyelectrolyte solution for 30 min for adsorption. The
polyelectrolyte pair that is first adsorbed also constitutes the
most external compartment of the tubes after template removal,
that is, the shell compartment. For these core−shell nanotubes,
the biocompatible shell compartment was initially made from
(1) poly-L-ornithine as polycation and (2) either hyaluronic
acid or ovalbumin as polyanion, and the rigidifying core
compartment was made from PAH and PSS (Table 1, iv and v).
Since PAH and PSS chains have to diffuse into narrower pores,
we also used a higher ionic strength with a small amount of
divalent ion.17,32 Following a similar procedure as before, at the
end of the LbL assembly the membrane was air-dried, the
polycarbonate dissolved, the nanotubes collected over a filter or
transferred and dispersed in an aqueous solution to be observed
by epi-fluorescence. Reasoning that our nanotube collection by
filtration can favor deformation of the tubes especially after
water contact, we used instead a droplet of dispersed tubes in
buffer solution and imaged it directly in the epi-fluorescence
microscope. The nanotubes dispersed in PBS buffer were also
pulsed into DCs and confocal images acquired after overnight
contact.
Figure 4 displays the core−shell LbL tube structures before
and after water contact, while Figure 2 (bars iv and v) shows
the values of calculated rigidity for these core−shell systems. In
general, core−shell nanotubes deform and break to a lesser
extent compared to simple assemblies, regardless of the
chemical nature of the softer shell compartment; in addition,
they exhibit negligible differences of rigidity with less than 5%
loss of rigidity index upon dispersion in an aqueous medium.
Apparently, the sole addition of the PAH/PSS compartment
improves significantly their stability, probably due to a lower
hydrophilicity and lesser sensitivity to pH or ionic strength
fluctuations. This results in the dimensions of the tubes
corresponding to the thickness of the template, even after
uptake by the DCs (Figure 4e,f).
Once proven that the core−shell architecture with soft and
rigid compartments is stable, we explored further possibilities to
combine the polyelectrolyte pairs in two compartments, and
analyze the influence of polyelectrolyte pair placement in the
assembly. As before, we selected a PAH/PSS-based rigidifying
compartment; the biocompatible compartment was made of a
(PLO/HA)4 polysaccharide layer that can be further function-
alized or cross-linked via to the carboxylic acid and amine
Figure 3. Uptake of LbL nanotubes of different size and chemistry by
dendritic cells: top (a, b): (PAH*/PSS)3; midsection (c, d): (PAH/
OVA*)3; bottom (e, f): (PLA/OVA*)3. Left column images (a, c, e)
are for tubes of 500 nm starting nominal diameter and 21 μm length;
the right column (b, d, e) are for tubes of 400 nm starting nominal
diameter and 10 μm length The polyelectrolytes indicated with a “*”
are stained by FITC (green), while the cell membrane is stained red
and the nuclei are stained blue.
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lateral groups with a final PLA/OVA layer for OVA delivery
(Table 1, vi and vii). In order to check the effect of the nature
of the shell, two series of tubes were made, one in which the
rigid compartment is in the shell (vi) and one in which it is in
the core (vii). For the uptake studies, we also added one more
factor by dispersing the tubes in either (1) PBS or (2)
ovalbumin in PBS, in which case we surmised that the very
external layer of the tubes would be changed to OVA due to its
adsorption on the tubes. The tubes were then immediately
placed in contact with DCs.
Figure 5 compares the uptake of LbL tubes with the rigid
synthetic compartment in the shell (a: shell of (PAH/PSS)6
and core of (PLO/HA)4/PLA/OVA*), or in the inner core (c:
shell of (PLO/HA)4/PLA/OVA* and core of (PAH/PSS)6).
The uptake of the tubes covered by an extra-layer of ovalbumin
is presented in Figure 5b and d, respectively. All the core−shell
tubes show a well-preserved morphology, and their shape and
dimensions is kept in aqueous solutions for about 3 months
(Supporting Information, SI Figure 1). The rigidity calculations
(Figure 2, vi and vii) also reveal that the core−shell tubes are
invariably rigid in both organic and aqueous solutions,
demonstrating the generality of our two-compartment strategy.
Moreover, the confocal images in Figure 5 show no major
difference in 24 h cell uptake for these four samples, as all of
them penetrate the membrane wall (the projections XZ and YZ
illustrate). In contrast with the results of Rubner et al. on B
cells;24 this is most probably due to the shorter interaction
times used by these authors (2 h), as well as the different cell
nature. At any rate, our results show that whatever the chemical
nature of the outer shell, intact rigid tubes as long as 10 μm are
taken by the dendritic cells, leading to substantial cargo
delivery.
■ CONCLUSIONS
We demonstrated that robust LbL tubes from 10 to 20 μm long
can be internalized by DCs while preserving their morphology.
The main advantage of long LbL nanotubes as drug carriers is
in the amount of active biomolecules contained in a single
carrier. For instance, a tube of 10 μm length and 500 nm
diameter has a volume that equals about 30× the one of a
spherical particle of 500 nm diameter. Thus, once internalized,
it will deliver a significantly increased loading to the targeted
cell.
In addition, long LbL nanotubes are easily distinguishable
units, easier to track by microscopy techniques, which is of
interest for in vitro studies. It is important to point out that the
cellular uptake of the long polyelectrolyte nanotubes presented
here raises questions about the internalization pathway. It has
been described in the literature that large particles are
internalized via macropinocytosis or phagocytosis,8,33 similarly
as it occurs for viruses and bacteria, with membrane channels as
large as 5 μm.34,35 Tracking the endocytosis process by imaging
at shorter time intervals until the uptake is complete would be
very interesting in this respect.
A careful selection of polyelectrolyte pairs arranged in a
core−shell structure is key to obtain stable nanostructures in
aqueous dispersions, such as a PAH/PSS-based rigid compart-
Figure 4. Core−shell LbL nanotubes and their uptake by DCs: (a, c,
e) [shell of (PLO/HA)6 and core of (PAH/PSS)4/(PAH*/PSS)2]; (b,
d, f) shell of (PLO/OVA*)6 and core of (PAH/PSS)6. The top images
(a, b) are nanotubes after dissolution of the PC membrane in
methylene chloride, whereas the middle row (c, d) are nanotubes
suspended in PBS buffer. The amount of tubes is lower than in Figure
3 because the suspension of the tubes in water is directly imaged here.
The tubes contain a green fluorescent compartment, the cell
membrane is stained red, and the nuclei are stained blue. Scale bars
are 10 μm.
Figure 5. In vitro uptake of LbL core−shell nanotubes by DCs
observed by confocal microscopy, (a) shell of (PAH/PSS)6 and core of
(PLO/HA)4/PLA/OVA*; (b) shell of OVA-(PAH/PSS)6 and core of
(PLO/HA)4/PLA/OVA*; (c) shell of (PLO/HA)4/PLA/OVA* and
core of (PAH/PSS)6; (d) shell of OVA/(PLO/HA)4/PLA/OVA* and
core of (PAH/PSS)6. Scale bars are 10 μm. Dotted lines indicate the
position of the transversal XZ and YZ planes.
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ment combined with a biocompatible PLO/OVA- and/or
PLO/HA-based soft compartment. Contrariwise, LbL tubes
that are exclusively based on polysaccharide or protein layers
are likely to deform, break, and entangle in aqueous solutions
and, therefore, present limited interest. The exact chemical
nature of the outer compartment does not affect internalization,
with reciprocal core−shell structures behaving identically. More
quantitative studies are however required to fully evaluate the
efficiency of transfection, which could vary depending on
nanotubes architecture.
Overall, our report corroborates the applicability of LbL
assembly and templating methods to build sturdy structures
with tunable properties, using a proper combination of natural
and synthetic polyelectrolytes acting in synergy. We have also
shown how a protein load incorporated in robust rigid tubes
could be transported to the cytoplasm of dendritic cells, which
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